Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Sodium Nitrite in Metabolic Syndrome and Hypertension
NCT02517697Phase 2Withdrawn
- Start
- Oct 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium nitrite in metabolic syndrome, hypertension (HTN). Planned start Oct 2020; status: withdrawn.
02
Drugs
sodium nitrite
03
Conditions
metabolic syndromehypertension (HTN)
Beyond the preview
Go deeper on NCT02517697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517697.